A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/1999
12/16/1999	WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999	WO1999054280B1 Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation
12/16/1999	WO1999050268A3 Substituted indolealkanoic acids
12/16/1999	CA2335339A1 .beta.-carboline compounds
12/16/1999	CA2334979A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
12/16/1999	CA2334970A1 Quinazolinone inhibitors of cgmp phosphodiesterase
12/16/1999	CA2334945A1 Imidazolyl derivatives
12/16/1999	CA2333629A1 Furopyridine derivatives and their therapeutical use
12/16/1999	CA2330238A1 Vaccine
12/16/1999	CA2321273A1 Novel analgesic agents
12/16/1999	CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999	CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	CA2319730A1 Bradykinin antagonists
12/16/1999	CA2319651A1 H1-histamine receptor antagonists
12/16/1999	CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999	CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999	CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999	CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999	CA2318055A1 .beta.2-adrenergic receptor agonists
12/15/1999	EP0963759A1 The use of a vital dye for facilitating surgical procedures for cataract extraction
12/15/1999	EP0963431A1 NOVEL FabH
12/15/1999	EP0963200A2 Methods and compositions for inhibition of angiogenesis
12/15/1999	EP0765305B1 Anti-inflammatory compounds
12/15/1999	EP0642504B1 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
12/15/1999	CN1238771A 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
12/15/1999	CN1238761A Benzamidoaldehydes and their use as cryteine protease inhibitors
12/15/1999	CN1238688A Thiol sulfonamide metalloprotease inhibitors
12/15/1999	CN1238213A Medicinal capsules for improving vision and its preparing method
12/15/1999	CN1238212A Liquid medicine for treating disseases of eye, ear, nose and throat
12/14/1999	US6001885 Retinoid inhibition of expression of VEGF
12/14/1999	US6001870 Nasopharynx administration of mupirocin for prophylactic treatment of recurrent otitis media
12/14/1999	US6001855 Thiazole derivatives
12/14/1999	US6001819 Bacterial inhibition with an oligosaccharide compound
12/14/1999	US6001603 Polynucleotide sequence coding for a staphylococcus enzmatic protein; for diagnosis, treatment and prevention of bacterial infections; bactericides
12/14/1999	US6001386 For treatment of uveitis eye disease
12/14/1999	US6001358 Useful for treatment of autoimmune diseases
12/14/1999	CA2181150C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
12/14/1999	CA2135487C Heteroaromatic quinuclidinenes, their use and preparation
12/09/1999	WO1999062883A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
12/09/1999	WO1999062549A1 Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases
12/09/1999	WO1999062538A1 Alpha-keto oxadiazoles as serine protease inhibitors
12/09/1999	WO1999062523A1 Bridged indenopyrrolocarbazoles
12/09/1999	WO1999062518A1 PYRROLO[2,3d]PYRIMIDINE COMPOSITIONS AND THEIR USE
12/09/1999	WO1999062504A2 Topical administration of oxazolidinones for transdermal delivery
12/09/1999	WO1999049885A3 The use of isolated domains of type iv collagen to modify cell and tissue interactions
12/09/1999	WO1999046367A3 Methods of diagnosis and triage using cell activation measures
12/09/1999	WO1998025648A3 Use of a texaphyrin in ocular diagnosis and therapy
12/09/1999	CA2333975A1 Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases
12/09/1999	CA2327326A1 Topical administration of oxazolidinones for transdermal delivery
12/08/1999	EP0961779A1 SUBSTITUTED AMINO BICYCLIC-$g(b)-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS
12/08/1999	CN1237981A Peptide diagnostic and therapeutic agent for autoimmune diseases
12/07/1999	US5998480 Pharmaceutical preparation containing nimesulide for topical use
12/07/1999	US5998467 Glaucoma, intraocular hypertension
12/07/1999	US5998460 Phenylcarbamates of (-)-eseroline, (-)-N1-noreseroline and (-)-N1-benzylnoreseroline: selective inhibitors of acetyl and butyrylcholinesterase, pharmaceutical compositions and method of use thereof
12/07/1999	US5998390 Combination of bisphosphonate and tetracycline
12/07/1999	CA2085163C Physiological tear compositions and methods for their preparation
12/07/1999	CA2002552C Pharmaceutical aqueous solution for ophthalmic use comprising a water solube pharmaceutically acceptable acid addition salt of ibopamine
12/02/1999	WO1999061600A2 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
12/02/1999	WO1999061590A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src
12/02/1999	WO1999061476A1 Peptide antiangiogenic drugs
12/02/1999	WO1999061466A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
12/02/1999	WO1999061444A2 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
12/02/1999	WO1999061440A1 Novel substituted imidazole compounds
12/02/1999	WO1999061437A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999	WO1999061426A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999	WO1999061423A1 New heterocyclically substituted amides, their production and their use
12/02/1999	WO1999061406A2 Antiangiogenic drug to treat cancer, arthritis and retinopathy
12/02/1999	WO1999061012A2 Therapeutic dinucleotide and derivatives
12/02/1999	WO1999060984A2 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases
12/02/1999	WO1999060948A2 Medium for treating eye diseases
12/02/1999	CA2333157A1 Novel substituted imidazole compounds
12/02/1999	CA2332772A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
12/02/1999	CA2332540A1 Therapeutic dinucleotide and derivatives
12/02/1999	CA2332459A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999	CA2332402A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999	CA2327541A1 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases
12/01/1999	EP0960882A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
12/01/1999	EP0960117A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
12/01/1999	EP0959903A1 NOVEL FabD
12/01/1999	EP0959883A1 Inhibitors of farnesyl-protein transferase
12/01/1999	EP0959781A1 Improved tissue destruction in cryosurgery by use of thermal hysteresis proteins
12/01/1999	EP0800504B1 Tricyclic retinoids, methods for their production and use
12/01/1999	EP0655056B1 Azacyclyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension
12/01/1999	EP0630244B1 Muscarinic agonists
12/01/1999	CN1237168A Bicyclic aryl carboxamides and their therapeutic use
12/01/1999	CN1237157A Lis-'delta'4 analogs of prostaglandins as ocular hypotensives
12/01/1999	CN1236614A Acetazolamide microemulsion as eyedrops for treating glaucoma and its preparing process
12/01/1999	CN1046942C Imidazopyridines
11/1999
11/30/1999	US5994549 Piperidine derivatives and process for their production

1 ... 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 ... 531